View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
December 20, 2021updated 11 Jul 2022 9:48am

Global supply chain crisis to continue to 2023 – leading macroeconomic influencers

US port bottlenecks and truck shortages are causing further delays in the supply chain crisis.

Some economists believe that it is not only taking much longer for US and the West to import goods amid a relentless pandemic, but it has become highly expensive as well.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

Adam Posen

Adam Posen, economist and president of the Peterson Institute for International Economics (PIIE) retweeted an interview shared by Chad P Bown, economist and senior fellow at the PIIE, on an insider’s views about the Covid-induced supply chain crisis. Phil Levy, chief economist at Flexport, a Francisco-based tech company providing global logistics services, believes that consumers flush with cash and the pandemic restrictions together will drive the demand for goods in the US and the West.

The Covid-19 pandemic has made goods ranging from kitchen appliances, chassis’ for trucks, to computer chips scarcer and more expensive than before the pandemic, he explains. In addition, he expects that the unprecedented crisis will not end before 2023.

The transit time for a container, he explains, was 71 days before the Covid-19 pandemic hit the US. However, post Covid the transit time for goods and containers from Shanghai to California and back is now taking logistics companies 117 days. Additionally, the surge in transport costs have hit lower-value goods the most, making it more difficult to restock.

Greg Ip

Greg Ip, chief economics commentator for The Wall Street Journal, shared an article on central bank officials being worried about the Covid-19 Omicron wave not only threatening to curtail economic growth, but putting more pressure on prices than the previous waves.

Experts believe that the pandemic’s first wave crushed consumer spending and inflation, but fear that a surge in Covid-19 cases could further stretch high inflation. Central banks, as a result, are preferring to unwind stimulus and raise interest rates – like in the US and UK – rather than loosening monetary policy to boost their economies as they did during the beginning of the Covid-19 pandemic.

Daniel Lacalle

Daniel Lacalle, economist and chief investment officer at Tressis Gestión SGIIC, retweeted a video on why the inflation pass through is quite slow in Europe as compared to how the US has been doing it. He explains how the eurozone has been performing in terms of Covid recovery as against other economies like Japan, the US, and China, and whether it will suffer the same power crisis as China and will be able to absorb the inflation.

Lacalle believes that everything happens quickly in the US. For instance, the country shut down its economy and business activities immediately during the Covid-19 outbreak in March 2020, leading to soaring unemployment rates initially, and then dramatically dropping like an opposite V shape. However, in the Eurozone everything happens more slowly. Therefore, it is a bigger risk, because in the domino effect, instead of being very quick and painful and quickly absorbed it is very slow.

 

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology